Kidney Cancer Study Puts Circulating Tumor DNA Assay to Test
The study will examine whether Natera’s circulating tumor DNA assay can distinguish between recurring and nonrecurring cases of kidney cancer.
Read More
Search Results for: lung cancer
OGT Expands Custom NGS Cancer Panel Content and Readies Enhanced Software for Release
The expanded SureSeq myPanel next-generation sequencing custom cancer panel now covers 120 fully optimized cancer-related genes.
Read MoreProteocyte AI Leverages Proscia Digital Pathology Platform to Predict Risk of Oral Cancer
Proscia and Proteocyte AI have signed an agreement to integrate Proscia’s technology with the Straticyte test for predicting the risk of progression to oral cancer.
Read More
ASCO, CAP Release Expert Review of Liquid Biopsy Tests in People with Cancer
An expert review from the American Society of Clinical Oncology and the College of American Pathologists has provided an assessment of current evidence about the use of liquid biopsy tests in oncology.
Read More
Single Blood Test Screens for Eight Common Cancers
The cancers that the test screens for—cancers of the breast, colorectum, esophagus, liver, lung, ovary, pancreas, and stomach—account for more than 60% of cancer deaths in the United States.
Read More